Original Research
Accepted on 04 May 2026
Nontuberculous mycobacteria pulmonary disease in Texas: an analysis of eight years of hospital discharge data
Frontiers in Tuberculosis
- 118 views
65 Publications
volumes
Volume 4 - 2026
Review
Accepted on 27 Apr 2026
Research overview—2025: integrating scientific progress to accelerate global tuberculosis elimination
Frontiers in Tuberculosis
- 205 views
Perspective
Published on 23 Apr 2026
Readiness assessment as a strategy, not an afterthought: leveraging implementation science to integrate tuberculosis comorbidity care in Pakistan's health system
Frontiers in Tuberculosis
doi 10.3389/ftubr.2026.1809118
- 483 views
Case Report
Accepted on 20 Apr 2026
Challenges in the Diagnosis and Treatment of Disseminated Tuberculosis in Infancy: A Case Report
Frontiers in Tuberculosis
- 228 views
Original Research
Published on 17 Apr 2026
Evaluation of the performance of promising host transcriptional biosignatures in predicting TB progression during a 1-year prospective cohort study in Indian household contacts
Frontiers in Tuberculosis
doi 10.3389/ftubr.2026.1750007
- 439 views
Original Research
Published on 10 Apr 2026
Immunometabolic reprogramming of Mycobacterium tuberculosis-responsive memory CD4+ T cell subsets is linked to long-term protective immunity
Frontiers in Tuberculosis
doi 10.3389/ftubr.2026.1783887
- 535 views
Editorial
Published on 01 Apr 2026
Editorial: Non-tuberculous mycobacteria and bronchiectasis
Frontiers in Tuberculosis
doi 10.3389/ftubr.2026.1819209
- 313 views
Original Research
Published on 26 Mar 2026
Dose optimization of inhaled tigecycline in humans to overcome inherent adverse events and maximize bacterial clearance using a physiologically-based pharmacokinetic modeling approach
Frontiers in Tuberculosis
doi 10.3389/ftubr.2026.1762713
- 472 views
- 1 citation
Review
Published on 25 Mar 2026
Advanced diagnostic methods for nontuberculous mycobacterial infections
Frontiers in Tuberculosis
doi 10.3389/ftubr.2026.1760581
- 725 views
Study Protocol
Published on 13 Feb 2026
An integrated psycho-social intervention to improve self-efficacy toward TB treatment uptake and infection prevention among patients and family caregivers: a multicentric implementation research study protocol
Frontiers in Tuberculosis
doi 10.3389/ftubr.2026.1713844
- 591 views
Original Research
Published on 12 Feb 2026
Acceptability and feasibility of oral swabs for tuberculosis diagnosis in young children: a qualitative study from Uganda and Peru
Frontiers in Tuberculosis
doi 10.3389/ftubr.2026.1726647
- 746 views
- 1 citation
Original Research
Published on 27 Jan 2026
The “yeast-drop” treatment protocol in the Drosophila model for rapid and cost-effective TB drug testing
Frontiers in Tuberculosis
doi 10.3389/ftubr.2026.1746664
- 677 views
Volume 3 - 2025
Original Research
Published on 16 Feb 2026
Evaluation of host-immune biomarker signatures as multiplex qPCR diagnostic assays: a pilot study toward meeting WHO target product profiles for TB diagnosis in India
Frontiers in Tuberculosis
doi 10.3389/ftubr.2025.1678039
- 919 views
Original Research
Published on 13 Jan 2026
Evaluation of a short, all oral treatment regimen including bedaquiline, delamanid, linezolid, clofazimine, and pyrazinamide named “Regimen C” for pre-XDR tuberculosis in Niger
Frontiers in Tuberculosis
doi 10.3389/ftubr.2025.1718997
- 693 views
Review
Published on 12 Jan 2026
Bidirectional pathogenesis between non-tuberculous mycobacteria and bronchiectasis: clinical insights, diagnostic challenges and future directions—Perspectives from South Asia
Frontiers in Tuberculosis
doi 10.3389/ftubr.2025.1735568
- 1,245 views
Original Research
Published on 09 Jan 2026
A synthesis of youth activation initiatives and their impact on tuberculosis knowledge, knowledge-seeking, and healthcare-seeking behavior in vulnerable populations
Frontiers in Tuberculosis
doi 10.3389/ftubr.2025.1668711
- 954 views
Original Research
Published on 17 Dec 2025
Proteomic insights into mycobacterial responses to elevated riboflavin reveal a role for flavin-sequestering proteins in flavin homeostasis
Frontiers in Tuberculosis
doi 10.3389/ftubr.2025.1719707
- 1,227 views
Review
Published on 12 Dec 2025
Mycobacteria as evolutionary drivers of host innate immunity: insights from comparing experimental host models
Frontiers in Tuberculosis
doi 10.3389/ftubr.2025.1735950
- 1,195 views
- 1 citation
Perspective
Published on 28 Nov 2025
Implementing TB-Stigma reduction interventions in High Burden Countries: a perspective on a conceptual framework
Frontiers in Tuberculosis
doi 10.3389/ftubr.2025.1721361
- 1,331 views
Original Research
Published on 06 Nov 2025
Low treatment completion rates reveal gaps in the LTBI care cascade among university students
Frontiers in Tuberculosis
doi 10.3389/ftubr.2025.1710215
- 1,408 views
Original Research
Published on 01 Oct 2025
Predicting treatment adherence in patients with drug-resistant tuberculosis: insights from socioeconomic, demographic, and clinical factors of patients in the rural Eastern Cape
Frontiers in Tuberculosis
doi 10.3389/ftubr.2025.1659333
- 2,118 views
- 2 citations
Original Research
Published on 25 Sep 2025
Country-level heterogeneity in MDR-TB drug susceptibility supports country-specific policy development
Frontiers in Tuberculosis
doi 10.3389/ftubr.2025.1667354
- 1,506 views
Original Research
Published on 02 Sep 2025
Targeted transcriptomic analyses of tuberculosis treatment response and outcomes in The Gambia
Frontiers in Tuberculosis
doi 10.3389/ftubr.2025.1540194
- 1,991 views
Review
Published on 12 Aug 2025
The value of LAM and LprG in extracellular vesicles in the diagnostic and therapeutic field of renal tuberculosis
Frontiers in Tuberculosis
doi 10.3389/ftubr.2025.1608780
- 1,934 views